23andMe Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Unlock the Full Value Chain Analysis for Deeper Insight
This 23andMe Value Chain Analysis helps you understand how the company creates value across its support and primary activities in one clear framework. This page already shows a real preview of the actual analysis, so you can review the structure and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Firm Infrastructure
23andMe's firm infrastructure is built around privacy, legal, compliance, finance, and board oversight for genetic data, which is core to trust and consent. The scale is real: 23andMe has served more than 15 million customers, so even small control gaps can hit a huge base. Strong governance also helps manage research use, partner contracts, and data-risk exposure.
Human Resource Management
In 2025, 23andMe's Human Resource Management depends on lab staff, bioinformaticians, data scientists, genetic counselors, privacy specialists, and customer support teams. Hiring and training these roles keeps DNA sample handling accurate and report interpretation consistent, while helping protect regulated consumer data. The need is clear: 23andMe had 15 million+ genotyped customers, so even small training gaps can affect trust and compliance.
Technology Development
23andMe's technology development turns one saliva sample into ancestry, health, and trait reports through genotyping, algorithmic scoring, and consent-based research analytics. In FY2025, that stack also supported data security and large-scale privacy controls as the business kept investing in software and platform upkeep while running a much smaller consumer base. The same layer helps package de-identified data for pharma and biotech research, which is a core monetization path.
Procurement
23andMe buys saliva kits, lab consumables, cloud data tools, and outsourced testing, so procurement sits right in its cost base. In fiscal 2025, tight sourcing mattered because every kit, reagent, and shipping step affected margins, turnaround time, and the customer experience. Better vendor terms and quality checks also help protect test accuracy, which is core to trust in genetic reports.
23andMe's Support Systems Hold the Line as Revenue and Cash Shrink
In FY2025, 23andMe's support activities were under strain: revenue fell to $192 million, net loss widened to $279 million, and cash dropped to $149 million, so governance, HR, technology, and procurement had to do more with less.
Its 15 million+ customers made privacy controls, lab staffing, and vendor quality checks central to trust and compliance.
That support stack also kept sample handling, data security, and research consent in place across a much smaller operating base.
| FY2025 metric | Value |
|---|---|
| Revenue | $192 million |
| Net loss | $279 million |
| Cash | $149 million |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
In FY2025, 23andMe's inbound logistics starts when customers mail back saliva kits and signed consent forms. The company must receive, label, verify, and route each sample fast, because chain of custody and sample integrity drive test quality. With over 14 million customers, this intake step is a high-volume control point, not just mail handling.
Operations
Operations are the core of 23andMe's value chain: saliva is processed, genotyping and quality checks run, and ancestry, health, and trait reports are produced. In fiscal 2025, 23andMe reported $219.1 million in revenue, showing how each kit feeds the main consumer business. Consent also matters: opted-in profiles help build the research dataset, which adds a second value stream from the same test.
Outbound Logistics
In fiscal 2025, 23andMe reported about $219 million in revenue, and most outbound delivery stayed digital through its secure customer portal. This cuts last-mile shipping cost and speeds report access, while kit fulfillment still uses physical shipping to reach customers without a retail store network. The model keeps distribution light, with far less inventory handling than a store-based chain.
Marketing and Sales
23andMe sells straight to consumers through digital ads, its site, and simple online funnels that push ancestry, health predisposition, and trait reports. Its value chain depends on turning the same customer base into repeat revenue through upgrades and research offers; by 2025, 23andMe had served over 15 million customers, so each new sale can add more data and more follow-on demand. That makes marketing and sales less about one purchase and more about conversion, retention, and lifetime value.
Service
Service in 23andMe Value Chain Analysis centers on post-test support, account access, privacy controls, and help with result interpretation. With over 15 million customers and genetic data that can affect family planning and health choices, clear support tools matter because confusion can hurt trust and repeat use.
In 2025, 23andMe's Chapter 11 filing made service even more critical, since users needed reassurance on data handling, refunds, and account control. Strong service protects the brand by reducing backlash around a product that is both highly personal and highly sensitive.
23andMe FY2025: 15M Customers, $219.1M Revenue, Chapter 11
In FY2025, 23andMe's primary activities centered on kit processing, genotyping, digital report delivery, and post-test support. With $219.1 million in revenue and over 15 million customers, the flow from saliva kit to secure online results stayed the main value driver. Chapter 11 in 2025 made privacy, refunds, and account help even more critical.
| FY2025 | Value |
|---|---|
| Revenue | $219.1M |
| Customers | 15M+ |
| Status | Chapter 11 |
Preview the Actual Deliverable
23andMe Reference Sources
This preview shows the actual 23andMe Value Chain Analysis document, not a simplified sample. What you see here is the same professional file the customer receives after purchase. Once checkout is complete, the full version is unlocked and ready to use.
Frequently Asked Questions
It starts with customer consent, saliva collection, and sample intake. The model depends on 1 at-home kit, 1 biological sample, and 3 core output families: ancestry, health predispositions, and traits. That simple front end lowers friction, while the back end turns the same sample into repeatable digital products and research assets.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.